Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Theodore Krupin"'
Autor:
Angelo P. Tanna, Daniel Sarezky, Nicholas J. Volpe, Aaron Cohen, Theodore Krupin, Charles Wm. Stewart
Publikováno v:
Journal of Glaucoma. 23:419-423
PURPOSE: To evaluate the effectiveness of a new binocular infrared computerized pupillometer in the quantitative measurement of the relative afferent pupillary response in patients with glaucoma by assessing the correlation of the intereye difference
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae4a75348e394be29088495ca94a6930
https://doi.org/10.1097/ijg.0b013e31827b1522
https://doi.org/10.1097/ijg.0b013e31827b1522
Autor:
Carlos Gustavo De Moraes, Jeffrey M. Liebmann, Theodore Krupin, Stuart K. Gardiner, Robert Ritch, David S. Greenfield
Publikováno v:
American Journal of Ophthalmology. 154:702-711
To investigate risk factors associated with visual field progression in the Low-pressure Glaucoma Treatment Study, a prospective trial designed to compare the effects of the alpha2-adrenergic agonist brimonidine tartrate 0.2% to the beta-adrenergic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19172e2f363d741d82a1e9bd617c91e3
https://doi.org/10.1016/j.ajo.2012.04.015
https://doi.org/10.1016/j.ajo.2012.04.015
Publikováno v:
Ophthalmology. 114:460-465
Objective To explore the relationship between asymmetric baseline intraocular pressure (IOP) and asymmetric visual field (VF) loss in the Low-Pressure Glaucoma Treatment Study. Design Randomized, multicenter, controlled clinical trial. Participants L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e640eb3fa0afed39cfa4cfb423ba0bef
https://doi.org/10.1016/j.ophtha.2006.06.056
https://doi.org/10.1016/j.ophtha.2006.06.056
Autor:
Theodore, Krupin
Publikováno v:
Canadian Journal of Ophthalmology. 42:414-417
Low-pressure (low-tension) glaucoma is reviewed in relation to neuroprotection, that is, the therapeutic strategy to keep neurons living and functionally connected to targets within the brain. Baseline results of the Low-Pressure Glaucoma Treatment S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc1de40b250c22767cc49c5c4ffe105
https://doi.org/10.3129/i07-043
https://doi.org/10.3129/i07-043
Autor:
John W. Yang, David S. Greenfield, Robert Ritch, Lisa F. Rosenberg, Jeffrey M. Liebmann, Theodore Krupin
Publikováno v:
Ophthalmology. 112:376-385
Objective The Low-Pressure Glaucoma Treatment Study (LoGTS) seeks to evaluate visual field stability in low-pressure glaucoma patients randomized to intraocular pressure reduction in both eyes with topical twice daily brimonidine tartrate 0.2% versus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfea7fa85143e476c9e8ee211ff07a31
https://doi.org/10.1016/j.ophtha.2004.10.034
https://doi.org/10.1016/j.ophtha.2004.10.034
Publikováno v:
Current Eye Research. 24:173-181
Adrenergic agents decrease intraocular pressure by reducing aqueous humor secretion from ciliary epithelial cells. Since the ionic concentration of aqueous humor contributes to intraocular pressure, we have investigated the effect of (-)-isoprotereno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00e04b30ea41d4567f73b91fd332ac1
https://doi.org/10.1076/ceyr.24.3.173.8300
https://doi.org/10.1076/ceyr.24.3.173.8300
Publikováno v:
Ophthalmology Clinics of North America. 13:545-551
As longevity increases among the elderly, the challenge of managing coexisting glaucoma and cataract is becoming ever more frequent. Modern surgical techniques for cataract removal (e.g., small incision phacoemulsification and temporal clear corneal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::800f943934c5ebad6c10a897a3fc5c4c
https://doi.org/10.1016/s0896-1549(05)70213-3
https://doi.org/10.1016/s0896-1549(05)70213-3
Autor:
Theodore Krupin, Carl B. Camras, Paul L. Kaufman, Mark B. Sherwood, Robert N. Weinreb, L. Jay Katz, Robert A. Schumer, Thom J. Zimmerman, Jacob T. Wilensky, George A. Cioffi, Don S. Minckler, Martin B. Wax, Jacqueline S. Lustgarten, William C. Stewart, Eve J. Higginbotham, Alan L. Robin, Johan Stjernschantz, Robert Ritch
Publikováno v:
American Journal of Ophthalmology. 126:390-399
PURPOSE To determine the efficacy and safety of latanoprost treatment for 1 year in glaucoma patients, and to evaluate the effects of switching from timolol to latanoprost therapy. METHODS Latanoprost 0.005% was topically applied once daily without m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7476a9befc474ad08b8624d563ac24a1
https://doi.org/10.1016/s0002-9394(98)00094-4
https://doi.org/10.1016/s0002-9394(98)00094-4
Publikováno v:
Ophthalmology. 105:88-93
Objective: The study aimed to determine whether topical dorzolamide and systemic acetazolamide have an additive effect on intraocular pressure (IOP) and aqueous humor formation (AHF). Design: This was a prospective, open-label, two-protocol clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8377180c337d8310e61a4797cff7544f
https://doi.org/10.1016/s0161-6420(98)91421-x
https://doi.org/10.1016/s0161-6420(98)91421-x
Publikováno v:
Seminars in Ophthalmology. 12:134-142
Latanoprost is a new topical ocular prostaglandin that decreases intraocular pressure (IOP) by increasing uveoscleral outflow. Its efficacy is comparable with that of timolol and it shows almost complete additivity with timolol. Once daily dosing of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef2ab4f947045e43646de42c7ec8cd53
https://doi.org/10.3109/08820539709059810
https://doi.org/10.3109/08820539709059810